Abstract:A delicate balance between programmed cell death and proliferation of intestinal epithelial cells (IEC) exists in the gut to maintain homeostasis. Homeostatic cell death programs such as anoikis and apoptosis ensure the replacement of dead epithelia without overt immune activation. In infectious and chronic inflammatory diseases of the gut, this balance is invariably disturbed by increased levels of pathologic cell death. Pathological forms of cell death such as necroptosis trigger immune activation barrier dysfunction, and perpetuation of inflammation. A leaky and inflamed gut can thus become a cause of persistent low-grade inflammation and cell death in other organs of the gastrointestinal (GI) tract, such as the liver and the pancreas. In this review, we focus on the advances in the molecular and cellular understanding of programmed necrosis (necroptosis) in tissues of the GI tract. In this review, we will first introduce the reader to the basic molecular aspects of the necroptosis machinery and discuss the pathways leading to necroptosis in the GI system. We then highlight the clinical significance of the preclinical findings and finally evaluate the different therapeutic approaches that attempt to target necroptosis against various GI diseases. Finally, we review the recent advances in understanding the biological functions of the molecules involved in necroptosis and the potential side effects that may occur due to their systemic inhibition. This review is intended to introduce the reader to the core concepts of pathological necroptotic cell death, the signaling pathways involved, its immuno-pathological implications, and its relevance to GI diseases. Further advances in our ability to control the extent of pathological necroptosis will provide better therapeutic opportunities against currently intractable GI and other diseases.

Necroptosis in Inflammatory Bowel Disease: A Potential Effective Target.

Necroptosis in Inflammatory Bowel Disease and Other Intestinal Diseases

The Function of Necroptosis and Its Treatment Target in IBD

[Research Progress on Receptor Interacting Proteins in Inflammation].

Necroptosis: A Novel Pathway In Neuroinflammation

Necroptosis is a key mediator of enterocytes loss in intestinal ischaemia/reperfusion injury.

A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease

Necroptosis inhibitors: mechanisms of action and therapeutic potential

Necroptosis and its role in infectious diseases

Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases

Programmed necrosis in the cross talk of cell death and inflammation.

Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.

A narrative review of the role of necroptosis in liver disease: a double-edged sword

Necroptosis: a regulated inflammatory mode of cell death

Necroptosis in health and diseases

ABIN3 Negatively Regulates Necroptosis-induced Intestinal Inflammation Through Recruiting A20 and Restricting the Ubiquitination of RIPK3 in Inflammatory Bowel Disease

Necrostatin-1 Reduces Intestinal Inflammation and Colitis-Associated Tumorigenesis in Mice

Rip1/Rip3-Regulated Necroptosis As A Target For Multifaceted Disease Therapy (Review)

The Potential Role of Necroptosis in Clinical Diseases (Review)

Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections